Central Sympathetic Inhibition: a Neglected Approach for Treatment of Cardiac Arrhythmias?

about

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.

P2860

Q47614541-7993E1A7-C150-482A-B6A3-4FD43B9B1AD1

P2860

Central Sympathetic Inhibition: a Neglected Approach for Treatment of Cardiac Arrhythmias?

Item

http://www.wikidata.org/entity/Q38701602

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Central Sympathetic Inhibition ...... atment of Cardiac Arrhythmias?

@en

type

Item

label

Central Sympathetic Inhibition ...... atment of Cardiac Arrhythmias?

@en

prefLabel

Central Sympathetic Inhibition ...... atment of Cardiac Arrhythmias?

@en

P1476

Central Sympathetic Inhibition ...... atment of Cardiac Arrhythmias?

@en

P2093

Dagmara Hering

http://www.w3.org/2001/XMLSchema#string

Erika Bontempelli

http://www.w3.org/2001/XMLSchema#string

Francesca Cagnoni

http://www.w3.org/2001/XMLSchema#string

Giovanni Locatelli

http://www.w3.org/2001/XMLSchema#string

Maurizio Destro

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Circadian variation of symptomatic paroxysmal atrial fibrillation. Data from almost 10 000 episodes.

The data monitoring experience in the MOXCON trial.

Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.

Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.

Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study.

P2888

s11906-015-0619-0

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11906-015-0619-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Markus P. Schlaich

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1040520057

http://www.w3.org/2001/XMLSchema#string

P698

26781253

http://www.w3.org/2001/XMLSchema#string

Central Sympathetic Inhibition: a Neglected Approach for Treatment of Cardiac Arrhythmias?

about

P2860

P2860

Central Sympathetic Inhibition: a Neglected Approach for Treatment of Cardiac Arrhythmias?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698